Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Oncology

Subspecialties Oncology

Precision Oncology Genomic Profiling: In-House or Centralized?

| Sponsored by Thermo Fisher Scientific

Panel discussion highlights the benefits of keeping it close

Diagnostics Omics

A Tipping Point for Comprehensive Genomic Profiling in Cancer

| Cindy Perettie

Precision medicine is key to every aspect of modern oncology – and comprehensive genomic profiling can help

Inside the Lab Technology and innovation

A New Dawn for Comprehensive Genomic Profiling with TruSight™ Oncology 500

| Sponsored by Illumina

Results from early access trials demonstrate the reproducibility and reliability of a pan-cancer next-generation sequencing assay

Inside the Lab Precision medicine

Prognostic Tumor Gene Test for Ovarian Cancer

| Olivia Gaskill

A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer

Inside the Lab Precision medicine

Spatial Biomarkers and Immunotherapy Response

| Cliff Hoyt

To improve immunotherapy outcomes, we need to explore new biomarkers that offer spatial resolution in the tumor microenvironment

Inside the Lab Precision medicine

Precision Oncology Flourishes In-House

| Tanya Ahmad

As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind

Outside the Lab Training and education

Changing the Cancer Landscape in the Developing World

| Luke Turner

We sit down with HRH Princess Dina Mired to find out what brought her to cancer advocacy and how she sees future cancer care in the developing world

Diagnostics Endocrinology

Cancer Drivers in the Dark Genome

| Michael Schubert

A new computational tool may help identify cancer driver mutations in noncoding regions of the genome

Subspecialties Liquid biopsy

Secrets in Circulating Tumor Biomarkers

| Michael Schubert

What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence

Subspecialties Histology

Reclassifying Ocular Pathology

Establishing an accurate, understandable classification system for conjunctival epithelial pigmentations


Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register